Abstract
Interleukin 6 (IL-6) is a pro-inflammatory cytokine upregulated in neurodegenerative contexts. The polymorphism IL-6 -174 G > C influences release levels of this cytokine. We aimed to evaluate the influence of IL-6 -174 G > C on global cognitive score of a group with cognitive impairment no dementia in one year of follow-up. Methods: The subjects were categorized in two groups: short-term decline in global cognitive score and those with short-term stability or improvement. IL-6 174 G > C information were compared among these groups. Results: We observed that individuals with cognitive impairment no dementia with GGlower genotype were more frequent among global cognitive score non-decliners while carriers of at least one Chigher allele were more frequent in the group with global cognitive score decliners (p = 0.012; RR = 3.095 IC95% = 1.087-8.812). Conclusion: These results suggest that the higher expression of IL-6 gene may be an independent risk factor for cognitive decline among individuals with cognitive impairment no dementia.
Original language | English (US) |
---|---|
Pages (from-to) | 899-902 |
Number of pages | 4 |
Journal | Arquivos de neuro-psiquiatria |
Volume | 73 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2015 |
Externally published | Yes |
Keywords
- Cognition
- Cognitive impairment no dementia
- IL-6
- Polymorphism
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Biological Psychiatry